Form 4: Director Sandra Trail Receives NHC Stock Option Grant
Statement of Changes in Beneficial Ownership
National HealthCare Corp director Sandra Trail was granted 7,500 stock options as part of the company's 2020 Omnibus Equity Incentive Plan.
Summary
- Director Sandra Y. Trail received a grant of 7,500 stock options for National HealthCare Corp (NHC) common stock.
- The options were granted on May 7, 2026, under the 2020 Omnibus Equity Incentive Plan.
- The exercise price for the new options is $171.42 per share.
- The options vest on May 7, 2027, and expire on May 6, 2031.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no immediate impact on company operations or financial health.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon exercise.
Risks
- Market volatility affecting the value of equity-based compensation.
- Potential dilution of share value if options are exercised.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of director equity compensation.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare services sector to ensure long-term alignment between leadership and shareholders.
Comparison to Industry Standards
- The use of an Omnibus Equity Incentive Plan is consistent with standard compensation practices for publicly traded healthcare companies like NHC.
- The vesting schedule of one year is standard for director-level equity compensation in the industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 7,500 stock options to Director Sandra Trail under the 2020 Omnibus Equity Incentive Plan. | 05/07/2026 | Standard alignment of director compensation with shareholder interests. |
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of the granted options on May 7, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/07/2026 | Grant date of stock options and date of filing. |
| 05/07/2027 | Vesting date for the 2026 option grant. |
| 05/06/2031 | Expiration date for the 2026 option grant. |
Keywords
National HealthCare Corp, NHC, Form 4, Insider Trading, Stock Options, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.